Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts, USA.
Curr Opin Clin Nutr Metab Care. 2018 Mar;21(2):121-125. doi: 10.1097/MCO.0000000000000451.
Disruption of metabolic homeostasis is universal in the critically ill. Macronutrients and micronutrients are major environmental regulators of metabolite production through their gene regulation effects. The study of large numbers of circulating metabolites is beginning to emerge through the comprehensive profiling of the critically ill. In the critically ill, metabolomic studies consistently show that changes in fatty acids, lipids and tryptophan metabolite pathways are common and are associated with disease state and outcomes.
Metabolomics is now being applied in research studies to determine the critical illness response to nutrient deficiency and delivery. Nutritional metabolomics approaches in nutrient deficiency, malnutrition and nutrient delivery have included single time point studies and dynamic studies of critically ill patients over time. Integration of metabolomics and clinical outcome data may create a more complete understanding of the control of metabolism in critical illness.
The integration of metabolomic profiling with transcription and genomic data may allow for a unique window into the mechanism of how nutrient deficiency and delivery alters cellular homeostasis during critical illness and modulates the regain of cellular homeostasis during recovery. The progress and the challenges of the study of nutritional metabolomics are reviewed here.
危重病患者的代谢稳态普遍受到破坏。宏量营养素和微量营养素通过其基因调节作用,成为代谢产物产生的主要环境调节剂。通过对危重病患者的全面分析,大量循环代谢物的研究开始出现。在危重病患者中,代谢组学研究一致表明,脂肪酸、脂质和色氨酸代谢物途径的变化很常见,并且与疾病状态和结局相关。
代谢组学现在正被应用于研究中,以确定营养缺乏和供给对危重病的反应。在营养缺乏、营养不良和营养供给方面,营养代谢组学方法包括对单个时间点的研究以及对危重病患者随时间变化的动态研究。将代谢组学和临床结果数据相结合,可能会更全面地了解在危重病中控制代谢的机制。
将代谢组学分析与转录组和基因组数据相结合,可能为了解营养缺乏和供给如何在危重病期间改变细胞内稳态以及调节恢复期间细胞内稳态的恢复提供独特的视角。本文综述了营养代谢组学研究的进展和挑战。